Device Vascular

Instylla Microcatheter 1.2

Payments companies reported to CMS as associated with Instylla Microcatheter 1.2. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$96Kassociated payments (2023-2025)
28clinicians with associated payments
2companies reporting

By year

2025 $96K

Payments reported as associated with Instylla Microcatheter 1.2, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Vascular & Interventional Radiology $93K
Diagnostic Ultrasound $2,813
Diagnostic Radiology $627
Pediatric Radiology $74.46

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Instylla Microcatheter 1.2

These are the largest totals companies reported as associated with Instylla Microcatheter 1.2. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
David Tahour Long Beach, CA Vascular & Interventional Radiology $55,253.89
Eric Gandras Manhasset, NY Vascular & Interventional Radiology $9,685.78
Nadine Abi-Jaoudeh Orange, CA Vascular & Interventional Radiology $8,713.76
Suvranu Ganguli Boston, MA Vascular & Interventional Radiology $5,393.57
Michael Soulen Philadelphia, PA Vascular & Interventional Radiology $5,368.00
Salomao Faintuch Boston, MA Diagnostic Ultrasound $2,812.50
Dimitry Rabkin Boston, MA Vascular & Interventional Radiology $2,700.00
Kei Yamada Atlanta, GA Vascular & Interventional Radiology $2,250.00
Resmi Charalel New York, NY Vascular & Interventional Radiology $786.64
Edgar St Amour Little Rock, AR Vascular & Interventional Radiology $625.40

Prescribed Instylla Microcatheter 1.2?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.